Revivent System Used Via LIVE Procedure In Italy
BioVentrix has reported the successful clinical use of its Revivent myocardial anchoring system, via Less Invasive Ventricular Enhancement or the LIVE procedure in three clinical procedures all conducted by Professor Claudio Muneretto, Director of the department of cardiac surgery, the Ospedale Civile, in Brescia, Italy. The successful procedures, used to reshape the left ventricle (LV), were performed on three patients, all men ages 68 to 77 years, suffering from advanced HF.
Professor Muneretto, stated that these patients were all experiencing a very poor quality of life before the LIVE procedure. Immediately after the procedure, the volume of the LV of each patient was reduced by 25-35%, and importantly, the procedures were performed without complications. The LIVE procedure and Revivent system provide a much-needed option for patients suffering from heart failure, particularly when medical therapy is no longer effective. The LIVE procedure using the Revivent system is performed without the need of cardiopulmonary bypass or making incisions into the heart.
The Revivent system received CE mark in December 2012 and clinical use has expanded from Eastern European clinical sites to major Western European markets including Germany, France, Portugal, Italy, and the UK. David Schickling, Vice President of sales and marketing at BioVentrix, stated that while clinical adoption of the Revivent system continues to grow, the company's forthcoming Revivent-TC product, a hybrid transcatheter approach, will enable even more patients to benefit from this technology.